Acute neuropathic joint disease: A medical emergency?

Diabetes Care

Volumn 28, Issue 12, 2005, Pages 2962-2964

  Tan, Ai Lyn ^a,b   Greenstein, Adam ^c   Jarrett, Stephen J ^d   McGonagle, Dennis ^a,b  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^b CALDERDALE ROYAL HOSPITAL   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

^d PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; DEOXYPYRIDINOLINE; PAMIDRONIC ACID;

ACUTE DISEASE; CELL ACTIVATION; CONTRAST ENHANCEMENT; DISEASE COURSE; EMERGENCY CARE; HUMAN; NEUROPATHIC JOINT DISEASE; NEUROPATHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOCLAST; SKIN TEMPERATURE; DIABETIC NEUROPATHY; EMERGENCY; PATHOPHYSIOLOGY; REVIEW;

ACUTE DISEASE; ARTHROPATHY, NEUROGENIC; DIABETIC NEUROPATHIES; EMERGENCIES; HUMANS;

EID: 33644821371     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.28.12.2962     Document Type: Note

References (19)

1. Sinacore DR: Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location. J Diabetes Complications 12:287-293, 1998
2. Jeffcoate W, Lima J, Nobrega L: The Charcot foot. Diabet Med 17:253-258, 2000
3. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S: Charcot neuroarthropathy in diabetes mellitus. Diabetologia 45:1085-1096, 2002
4. Cavanagh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ: Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 17:201-209, 1994
5. Allman RM, Brower AC, Kotlyarov EB: Neuropathic bone and joint disease. Radiol Clin North Am 26:1373-1381, 1988
6. Reiner M, Scurran BL, Karlin JM, Silvani SH: The neuropathic joint in diabetes mellitus. Clin Podiatr Med Surg 5:421-437, 1988
7. Wilson M: Charcot foot osteoarthropathy in diabetes mellitus. Mil Med 156:563-569, 1991
8. Greenstein AS, Marzo-Ortega H, Emery P, O'Connor P, McGonagle D: Magnetic resonance imaging as a predictor of progressive joint destruction in neuropathic joint disease. Arthritis Rheum 46:2814-2815, 2002
9. Gupta R: A short history of neuropathic arthropathy. Clin Orthop Relat Res 43-49, 1993
10. Weishaupt D, Schweitzer ME, Alam F, Karasick D, Wapner K: MR imaging of inflammatory joint diseases of the foot and ankle. Skeletal Radiol 28:663-669, 1999
11. Selby PL, Young MJ, Boulton AJ: Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11:28-31, 1994
12. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ: Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 44:2032-2037, 2001
13. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM: Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 43:285-289, 2004
14. Carbone LD, Nevitt MC, Wildy K, Barrow KD, Harris F, Felson D, Peterfy C, Visser M, Harris TB, Wang BW, Kritchevsky SB: The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50:3516-3525, 2004
15. Boulton AJ: Pressure and the diabetic foot: clinical science and offloading techniques. Am J Surg 187:17S-24S, 2004
16. Bell NH: RANK ligand and the regulation of skeletal remodeling. J Clin Invest 111:1120-1122, 2003
17. Jeffcoate W: Vascular calcification and osteolysis in diabetic neuropathy-is RANKL the missing link? Diabetologia 47:1488-1492, 2004
18. Rodan GA, Martin TJ: Therapeutic approaches to bone diseases. Science 289:1508-1514, 2000
19. Duong LT, Rodan GA: Regulation of osteoclast formation and function. Rev Endocr Metab Disord 2:95-104, 2001